Biotech Values

[mouton29]

<<Your post is one of the very few times—perhaps the only time—where I’ve seen someone acknowledge that selling calls ended up costing money. >>

So his immediate cost was $.93 per share less the premium he got for writing the call. I'm going to guess that overall, the strategy was profitable for poorgrad compared to buy and hold -- perhaps substantially so.